Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.489, 2005-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
New guidelines target type 2 DM at global level
Inpharma, Vol. 1, Iss. 1510, 2005-01 ,pp. :
Access to resources
Recommend
Adding a thiazolidinedione a valid option in type 2 DM
Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. :
Pioglitazone economically attractive for type 2 DM in Canada
Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. :
Pioglitazone economically attractive for type 2 DM in Canada
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 356, 2002-01 ,pp. :
DM programme effective in type 2 diabetes mellitus
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 354, 2002-01 ,pp. :